Ogsiveo™ (nirogacestat) – New orphan drug approval
November 27, 2023 - The FDA announced the approval of SpringWorks Therapeutics’ Ogsiveo (nirogacestat), for adult patients with progressing desmoid tumors who require systemic treatment.
Download PDF
